Law & Medicine

Complementary and alternative medicine


 

Dr. Tan is emeritus professor of medicine and former adjunct professor of law at the University of Hawaii, Honolulu. This article is modified from a chapter in the author’s book, “Medical Malpractice: Understanding the Law, Managing the Risk.” It is meant to be educational and does not constitute medical, ethical, or legal advice. For additional information, readers may contact the author at siang@hawaii.edu.

References

1. Wengel v. Herfert, 473 N.W.2d 741 (1991).

2. Salazar v. Ehmann, 505 P.2d 387 (1972).

3. Miyamoto v. Lum and Lazo, 84 P.3d 509 (2004).

4. Rosenberg v. Jing Jiang, 153 A.D.3d 744 (2017).

5. Wallman v. Kelley, 976 P.2d 330 (1998).

6. Charell v. Gonzales, 673 N.Y.S. 2d 685 (1998).

7. Gonzales v. NYS DOH, 232 A.D.2d 886 (1996).

8. Schneider v. Revici, 817 F. 2d 987 (1987).

Pages

Recommended Reading

Hearing drills into patient impact of ACA legal challenge
MDedge Rheumatology
Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale
MDedge Rheumatology
Terminating an employee
MDedge Rheumatology
Conservatism spreads in prostate cancer
MDedge Rheumatology
Survey: Health care costs, access unlikely to improve in 2019
MDedge Rheumatology
Fund projects, not people to address gender bias in research funding
MDedge Rheumatology
ONC aims to help docs, patients with information sharing in proposed rule
MDedge Rheumatology
Culture change needed to improve gender inequalities in medicine
MDedge Rheumatology
A prescription for medicine’s gender inequality
MDedge Rheumatology
McAneny: Transparency needed for meaningful talk on drug pricing
MDedge Rheumatology